Human neutrophil peptides 1-3 are useful biomarkers in patients with active ulcerative colitis

Inflammatory Bowel Diseases

Volumn 15, Issue 6, 2009, Pages 909-917

  Kanmura, Shuji ^a   Uto, Hirofumi ^a,e   Numata, Masatsugu ^b   Hashimoto, Shinichi ^a   Moriuchi, Akihiro ^a   Fujita, Hiroshi ^a   Oketani, Makoto ^a   Ido, Akio ^a   Kodama, Mayumi ^c   Ohi, Hidehisa ^d   Tsubouchi, Hirohito ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY HOSPITAL   (Japan)

^c UNIVERSITY OF MIYAZAKI   (Japan)

^d Imamura Hospital   (Japan)

^e NONE   (Japan)

Author keywords

Biomarkers; Human neutrophil peptides 1 3; Inflammatory bowel disease; Proteomics; SELDI TOF MS; Ulcerative colitis

Indexed keywords

CORTICOSTEROID; MESALAZINE;

ADOLESCENT; ADULT; AGED; ARTICLE; COLITIS; COLORECTAL CANCER; CONTROLLED STUDY; CORTICOSTEROID THERAPY; CROHN DISEASE; DISEASE ACTIVITY; DISEASE MARKER; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOASSAY; MAJOR CLINICAL STUDY; MALE; MOLECULAR WEIGHT; PEPTIDE ANALYSIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN STRUCTURE; PROTEOMICS; REMISSION; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; TREATMENT RESPONSE; ULCERATIVE COLITIS;

ADOLESCENT; ADULT; AGED; ALPHA-DEFENSINS; BIOLOGICAL MARKERS; CHILD; COLITIS, ULCERATIVE; FEMALE; HUMANS; INTESTINES; MALE; MIDDLE AGED; NEUTROPHILS; PREDICTIVE VALUE OF TESTS; PROTEIN ARRAY ANALYSIS; YOUNG ADULT;

EID: 67650273609     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.20854     Document Type: Article

References (35)

1. Xavier RJ, Podolsky DK. Unravelling the pathogenesis of inflammatory bowel disease. Nature. 2007;448:427-434.
2. Podolsky DK. Inflammatory bowel disease. N Engl J Med. 2002;347: 417-429.
3. Mazlam MZ, Hodgson HJ. Peripheral blood monocyte cytokine production and acute phase response in inflammatory bowel disease. Gut. 1992;33:773-778.
4. Vermeire S, Van Assche G, Rutgeerts P. Laboratory markers in IBD: useful, magic, or unnecessary toys? Gut. 2006;55:426-431.
5. Sutherland LR, Martin F, Greer S, et al. 5-Aminosalicylic acid enema in the treatment of distal ulcerative colitis, proctosigmoiditis, and proctitis. Gastroenterology. 1987;92:1894-1898.
6. Andre C, Descos L, Landais P, et al. Assessment of appropriate laboratory measurements to supplement the Crohn's disease activity index. Gut. 1981;22:571-574.
7. Kanmura S, Uto H, Kusumoto K, et al. Early diagnostic potential for hepatocellular carcinoma using the SELDI ProteinChip system. Hepatology. 2007;45:948-956.
8. de Seny D, Fillet M, Meuwis MA, et al. Discovery of new rheumatoid arthritis biomarkers using the surface-enhanced laser desorption/ ionization time-of-flight mass spectrometry ProteinChip approach. Arthritis Rheum. 2005;52:3801-3812.
9. Ganz T, Selsted ME, Szklarek D, et al. Defensins. Natural peptide antibiotics of human neutrophils. J Clin Invest. 1985; 76:1427-1435.
10. de Dombal FT, Softley A. IOIBD report no. 1: Observer variation in calculating indices of severity and activity in Crohn's disease. Gut. 1987;28:474-481.
11. Christian M, Günther E, Bettina S, et al. A technical triade for proteomic identification and characterization of cancer biomarkers. Cancer Res. 2004;64:4099-4104.
12. Melle C, Ernst G, Schimmel B, et al. Discovery and identification of alpha-defensins as low abundant, tumor-derived serum markers in colorectal cancer. Gastroenterology. 2005;129:66-73.
13. Adam BL, Qu Y, Davis JW, et al. Serum protein fingerprinting coupled with a pattern-matching algorithm distinguishes prostate cancer from benign prostate hyperplasia and healthy men. Cancer Res. 2002;62: 3609-3614.
14. Albrethsen J, Moller CH, Olsen J, et al. Human neutrophil peptides 1, 2 and 3 are biochemical markers for metastatic colorectal cancer. Eur J Cancer. 2006:42;3057-3064.
15. Cunliffe RN. Alpha-defensins in the gastrointestinal tract. Mol Immunol. 2003;40:463-467.
16. Schmitz H, Barmeyer C, Fromm M, et al. Altered tight junction structure contributes to the impaired epithelial barrier function in ulcerative colitis. Gastroenterology. 1999;116:301-309.
17. Sugimura K, Asakura H, Mizuki N, et al. Analysis of genes within the HLA region affecting susceptibility to ulcerative colitis. Hum Immunol. 1993;36:112-118.
18. Kobayashi K, Atoh M, Konoeda Y, et al. HLA-DR, DQ and T cell antigen receptor constant beta genes in Japanese patients with ulcerative colitis. Clin Exp Immunol. 1990;80:400-403.
19. van Wetering S, Sterk PJ, Rabe KF, et al. Defensins: key players or bystanders in infection, injury, and repair in the lung? J Allergy Clin Immunol. 1999;104:1131-1138.
20. Cunliffe RN, Kamal M, Rose FR, et al. Expression of antimicrobial neutrophil defensins in epithelial cells of active inflammatory bowel disease mucosa. J Clin Pathol. 2002;55:298-304.
21. Sakamoto N, Mukae H, Fujii T, et al. Differential effects of alpha- and beta-defensin on cytokine production by cultured human bronchial epithelial cells. Am J Physiol Lung Cell Mol Physiol. 2005;288:508-513.
22. Merlin D, Yue G, Lencer WI, et al. Cryptdin-3 induces novel apical conductance(s) in Cl-secretory, including cystic fibrosis, epithelia. Am J Physiol Cell Physiol. 2001;280:296-302.
23. Fahlgren A, Hammarstrom S, Danielsson A, et al. Increased expression of antimicrobial peptides and lysozyme in colonic epithelial cells of patients with ulcerative colitis. Clin Exp Immunol. 2003;131:90-101.
24. Ashitani J, Mukae H, Nakazato M, et al. Elevated pleural fluid levels of defensins in patients with empyema. Chest. 1998;113:788-794.
25. Imada A, Ina K, Shimada M, et al. Coordinate upregulation of interleukin-8 and growth-related gene product-alpha is present in the colonic mucosa of inflammatory bowel. Scand J Gastroenterol. 2001;36:854-864.
26. McCormick BA, Hofman PM, Kim J, et al. Surface attachment of Salmonella typhimurium to intestinal epithelia imprints the subepithelial matrix with gradients chemotactic for neutrophils. J Cell Biol. 1995; 131:1599-1608.
27. Bulois P, Tremaine WJ, Maunoury V, et al. Pouchitis is associated with mucosal imbalance between interleukin-8 and interleukin-10. Inflamm Bowel Dis. 2000;6:157-164.
28. Lampinen M, Ronnblom A, Amin K, et al. Eosinophil granulocytes are activated during the remission phase of ulcerative colitis. Gut. 2005;54: 1714-1720.
29. Nikolaus S, Bauditz J, Gionchetti P, et al. Increased secretion of pro-inflammatory cytokines by circulating polymorphonuclear neutrophils and regulation by interleukin 10 during intestinal inflammation. Gut. 1998;42:470-476.
30. Kucharzik T, Walsh SV, Chen J, et al. Neutrophil transmigration in inflammatory bowel disease is associated with differential expression of epithelial intercellular junction proteins. Am J Pathol. 2001;159:2001-2009.
31. Andoh A, Yoshida T, Yagi Y, et al. Increased aggregation response of platelets in patients with inflammatory bowel disease. J Gastroenterol. 2006;41:47-54.
32. Sawada K, Muto T, Shimoyama T, et al. Multicenter randomized controlled trial for the treatment of ulcerative colitis with a leukocytapheresis column. Curr Pharm Des. 2003;9:307-321.
33. Sawada K, Ohnishi K, Fukui S, et al. Leukocytapheresis therapy, performed with leukocyte removal filter, for inflammatory bowel disease. J Gastroenterol. 1995;30:322-329.
34. Fukunaga K, Fukuda Y, Yokoyama Y, et al. Activated platelets as a possible early marker to predict clinical efficacy of leukocytapheresis in severe ulcerative colitis patients. J Gastroenterol. 2006;41:524-532.
35. Panyutich AV, Panyutich EA, Krapivin VA, et al. Plasma defensin concentrations are elevated in patients with septicemia or bacterial meningitis. J Lab Clin Med. 1993;122:202-207.